» Articles » PMID: 2163725

Excitation of Supraoptic Vasopressin Cells by Stimulation of the A1 Noradrenaline Cell Group: Failure to Demonstrate Role for Established Adrenergic or Amino Acid Receptors

Overview
Journal Brain Res
Specialty Neurology
Date 1990 May 14
PMID 2163725
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of adrenergic and excitatory amino acid antagonists on supraoptic nucleus (SON) neurosecretory cell responses to stimulation of the A1 noradrenaline (NA) cell group were examined in anaesthetized male rats. As in previous studies, delivery of cathodal pulses (100 microA, 1 ms pulses, 1 Hz) to the A1 region of the caudal ventrolateral medulla excited spontaneously active, antidromically identified neurosecretory cells, the majority of which were identified as arginine vasopressin (AVP) secreting on the basis of basal discharge patterns and responses to abrupt increases in arterial blood pressure. Administration of alpha- and beta-adrenoreceptor antagonists, by systemic or intracerebroventricular delivery of a bolus, or by direct pressure injection into the SON, did not alter neurosecretory cell responses to A1 stimulation, even when doses applied exceeded that required for blockade of excitations elicited by local application of NA. Application of the broad spectrum excitatory amino acid antagonist kynurenic acid (5-40 mM) blocked the excitatory effects of locally applied glutamate (100 microM) and transiently inhibited spontaneous activity, but failed to alter the excitatory effects of A1 region stimulation on SON cells. Identical effects were obtained with a selective kainate/quisqualate receptor antagonist. These data indicate that neurosecretory cell responses to activation of the A1 cell group are unaltered by antagonists of alpha- and beta-adrenoreceptors, or excitatory amino acid receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Physiological regulation of magnocellular neurosecretory cell activity: integration of intrinsic, local and afferent mechanisms.

Brown C, Bains J, Ludwig M, Stern J J Neuroendocrinol. 2013; 25(8):678-710.

PMID: 23701531 PMC: 3852704. DOI: 10.1111/jne.12051.


Diverse roles of G-protein coupled receptors in the regulation of neurohypophyseal hormone secretion.

Sladek C, Song Z J Neuroendocrinol. 2011; 24(4):554-65.

PMID: 22151700 PMC: 3314102. DOI: 10.1111/j.1365-2826.2011.02268.x.


Multiple alpha1-adrenergic receptor subtypes support synergistic stimulation of vasopressin and oxytocin release by ATP and phenylephrine.

Song Z, Gomes D, Stevens W, Sladek C Am J Physiol Regul Integr Comp Physiol. 2010; 299(6):R1529-37.

PMID: 20881098 PMC: 3007183. DOI: 10.1152/ajpregu.00532.2010.


Role of neurokinin 3 receptors in supraoptic vasopressin and oxytocin neurons.

Howe H, Somponpun S, Sladek C J Neurosci. 2004; 24(45):10103-10.

PMID: 15537880 PMC: 6730173. DOI: 10.1523/JNEUROSCI.3164-04.2004.


Purinergic and adrenergic agonists synergize in stimulating vasopressin and oxytocin release.

Kapoor J, Sladek C J Neurosci. 2000; 20(23):8868-75.

PMID: 11102496 PMC: 6773085.